Janine Mansi - Concepedia

Author

Janine Mansi

Also Known As

Ernie Marshall, J L Mansi, J Mansi, J. L. MANSI, J. L. Mansi, J. MANSI, J. Mansi, J.L. Mansi, Janine L Mansi, Janine L. Mansi

196

Publications

11.2K

Citations

H-Index

Concepts

All Affiliations

St George's Hospital Royal Marsden Hospital Royal Marsden NHS Foundation Trust Guy's and St Thomas' NHS Foundation Trust King's College London

About

Janine Mansi is an author at St George's Hospital specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	47	4.1K
2	Health Sciences	10	11	1.5K
3	Cell Biology	2	2	349
4	Public Health	1	1	256
5	Gastroenterology	1	1	22

Janine Mansi

Publications

10K

Citations

H-Index

Page 1

	Year	Citations
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. Andrew Webb, David Cunningham, J.H. Scarffe, Journal of Clinical Oncology	1997	872
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Miguel Martín, Frankie A. Holmes, Bent Ejlertsen, The Lancet Oncology 5-Year AnalysisBreast OncologyOncologyHealth SciencesClinical Trials	2017	578
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Arlene Chan, Suzette Delaloge, Frankie A. Holmes, The Lancet Oncology Breast OncologyHealth SciencesMedicineClinical TrialsImmune Checkpoint Inhibitor	2016	551
Bisphosphonates induce apoptosis in human breast cancer cell lines S G Senaratne, Grisha Pirianov, Janine Mansi, British Journal of Cancer	2000	422
Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer Charles Butts, Nevin Murray, Andrew W. Maksymiuk, Journal of Clinical Oncology	2005	420
Duration of Chemotherapy in Advanced Non–Small-Cell Lung Cancer: A Randomized Trial of Three Versus Six Courses of Mitomycin, Vinblastine, and Cisplatin Ian E. Smith, Mary O’Brien, Denis Talbot, Journal of Clinical Oncology	2001	311
Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study Janine Mansi, Helen Gogas, Judith M Biss, The Lancet Surgical OncologyPrimary-breast-cancer PatientsBreast OncologyMedicinePathology	1999	302
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial Justin S. Waters, A. Norman, David Cunningham, British Journal of Cancer	1999	278
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial Helena Earl, Louise Hiller, Anne-Laure Vallier, The Lancet	2019	277
A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF) Michael Findlay, David Cunningham, A. Norman, Annals of Oncology	1994	259

Page 1